Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Common Stock · CUSIP: 46333X108
Event date: 2025-03-31
- Filing-level shares
- 15,696,161
- Percent of class
- 9.80%
- The Vanguard Group
Shares: 15,696,161 · Class: 9.80%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000614
- Form type
- SCHEDULE 13G/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership